The effect of glycopyrronium and indacaterol, as monotherapy and in combination, on the methacholine dose-response curve of mild asthmatics: a randomized three-way crossover study

Table 2 Non-hyperresponsive non-asthmatic participants demographics

Participant	Gender	Age (years)	Height (cm)	BMI (kg/m²)	Mean FEV₁/FVC	Mean Baseline FEV₁ (L)	Mean Baseline FEV₁ (% Predicted)
H01	F	25	163	20	0.76	3.64	112
H02	F	22	168	21	0.83	3.10	88
H03	F	18	180	21	0.90	3.31	82
H04	F	36	163	20	0.78	2.57	83
H05	M	26	180	24	0.80	4.83	103
H06	M	20	170	30	0.78	3.33	77
H07	M	20	170	28	0.71	3.77	88
H08	M	27	170	33	0.85	4.78	115
H09	M	29	164	25	0.90	3.43	90
H10	M	34	175	30	0.84	4.15	98
H11	F	47	173	24	0.75	3.30	101
H12	F	20	170	30	0.81	4.00	111
H13	F	22	168	19	0.87	3.44	99
H14	F	35	157	26	0.81	3.30	113
H15	M	64	178	28	0.80	2.90	84
Means:	47% Male	30 [12]	170 [7]	25 [4]	0.81 [0.05]	3.59 [0.63]	96 [13]

BMI body mass index, FEV ₁, forced expiratory volume in 1 s, FVC forced vital capacity; [], standard deviation

ISSN: 1465-993X